Acne & the Microbiome: Beyond the Bacterial Paradigm

by f.c., Malezia

Introduction

Acne vulgaris remains one of the most common dermatological conditions worldwide, characterized by comedones, papules, pustules, and sometimes nodules primarily on the face, chest, and back. For decades, the prevailing understanding was that Cutibacterium acnes (formerly Propionibacterium acnes) drives the disease by thriving in a lipid-rich, oxygen-poor follicular environment. Indeed, older studies focused heavily on bacterial culture and antibiotic therapy, establishing C. acnes as a principal pathogen.

However, emerging research has revealed a far more diverse microbial community on acne-prone skin. Next-generation sequencing and PCR-based analyses have identified Malassezia yeasts—especially M. restricta and M. globosa—as frequent co-inhabitants of acne lesions [1,2]. Recent reviews similarly propose that multiple fungi and bacteria orchestrate inflammatory skin conditions via dysregulated immune responses—further bolstering a polymicrobial model of acne pathogenesis. [3]

These findings challenge the bacterial-centric model, suggesting that acne is better understood as a dysbiotic condition involving the interplay of multiple microbes and host factors. The inclusion of fungal components, in particular, has reshaped our understanding of acne’s etiology and progression. This article examines the historical evolution of acne microbiology research and presents the latest evidence supporting a comprehensive, microbiome-driven approach to acne pathogenesis.

Historical Timeline of Acne Microbiology Research

Early Perspectives: The Bacterial-Centric Era

In the mid-20th century, clinical observations linked C. acnes overgrowth to acne’s inflammatory lesions. Early studies relied almost exclusively on culturing techniques—skin surface swabs and occasional biopsies—to isolate microorganisms from acne sites. These methods could easily grow C. acnes, which flourishes on standard anaerobic media, reinforcing the notion that a single bacterial pathogen was responsible for acne flare-ups. Meanwhile, yeasts such as Malassezia were rarely considered, due partly to the difficulty in culturing these lipid-dependent fungi on conventional media.

Methodological Shifts and First Indications of Malassezia

By the 1980s, a few groups began examining yeasts in acne lesions using specialized oil-enriched media. One landmark culture-based study identified Malassezia in a notable fraction of inflamed acne lesions [5]. However, because culturing Malassezia is technically challenging and often yields false negatives, many researchers either failed to detect it or dismissed it as an incidental contaminant. This discrepancy persisted well into the 2000s, as evidence for Malassezia in acne was inconsistently reported.

PCR and Early DNA-Based Studies (2010s)

The introduction of polymerase chain reaction (PCR) provided a more sensitive method to detect Malassezia. Researchers who applied species-specific primers to acne samples consistently found Malassezia DNA, revealing yeast populations often missed by culturing [1,2,4]. A pivotal 2016 study sampled follicular contents from active lesions and detected large quantities of Malassezia, correlating its presence with the degree of inflammation [4]. These findings directly challenged older conclusions that acne was solely bacterial, catalyzing broader interest in skin fungal ecology.

Next-Generation Sequencing (2016–2020)

As next-generation sequencing (NGS) gained traction, microbiologists moved beyond targeted PCR to deep profiling of the entire microbial community within acne lesions. High-throughput 16S and internal transcribed spacer (ITS) sequencing revealed that Malassezia is not only present but frequently the dominant fungal genus in acne-prone skin [6]. Parallel analyses showed that C. acnes coexists with a range of staphylococci, corynebacteria, and other microorganisms, highlighting the polymicrobial nature of acne.

Recent Advances (2020–2025)

In the early 2020s, dedicated pustule-microbiome investigations reaffirmed Malassezia as a resident inside acne lesions, particularly within comedonal contents [7,8]. Deep metagenomic studies also pointed to potential synergistic mechanisms, such as co-occurring bacterial and fungal lipase activity, that amplify follicular inflammation. While some studies observed similar Malassezia abundance in healthy controls [10], researchers sampling within lesions consistently found robust fungal colonization, strengthening the case for Malassezia as a contributor to acne pathogenesis.

Advancements in Microbiome Research (2020–2025)

PCR Sequencing and Targeted Analyses

PCR amplification of fungal DNA has become standard in dermatological microbiome investigations, enabling researchers to bypass the limitations of fungal culture. Quantitative PCR (qPCR) further refines this approach, providing exact counts of microbial load. These sensitive assays reveal that M. restricta and M. globosa—both highly lipophilic species—dominate the facial skin of many acne patients [2,4]. Notably, some groups have found specific seasonal or environmental conditions favor one species over the other, hinting at Malassezia’s adaptability in follicular niches.

Deep Microbiome Profiling

High-throughput amplicon sequencing (16S for bacteria and ITS or 18S for fungi) has revolutionized our understanding of acne’s polymicrobial environment. Studies using next-generation sequencing consistently detect Malassezia in comedonal extracts alongside C. acnes, Staphylococcus epidermidis, and other skin microbes [7,8,11]. While C. acnes often dominates the bacterial fraction, Malassezia emerges as the principal fungus. These approaches also expose minor players (e.g., Corynebacterium, rare Candida species) that may modulate lesion severity or therapeutic responses [9,10].

Interestingly, a recent study focusing on subclinical (mild-to-moderate) acne found that bacterial alpha-diversity decreases significantly even at early stages, while Malassezia abundance remained largely unchanged compared to non-acne controls. This suggests that bacterial dysbiosis may precede or amplify the fungal component in early acne lesions, with Malassezia providing a primed background that can become pro-inflammatory when microbial shifts disrupt follicular homeostasis. [12]

Ecological Insights and Functional Potential

A major advantage of modern sequencing lies in elucidating functional genes—particularly those encoding lipases and inflammatory mediators. Malassezia harbors potent lipases that can break down sebum triglycerides, generating free fatty acids known to exacerbate keratin plugging and follicular inflammation [4,6,8,11]. Moreover, advanced “multi-omics” can capture metabolite profiles, offering clues about cross-feeding and synergy between fungal and bacterial species within the acne microenvironment. These ecological insights advance a more nuanced view of acne as a dysbiotic condition rather than a single-pathogen disease.

Microbial Ecology of Acne Lesions

Acne as a Dysbiotic Condition

The concept of dysbiosis refers to an altered microbial community that can disrupt host homeostasis. In acne, multiple commensals co-occupy the sebaceous follicle, but an imbalance in their abundance and metabolic activities may trigger or sustain inflammation. C. acnes and Malassezia, for instance, both utilize lipids in sebum, yet the byproducts of their metabolism differ. Certain free fatty acids, produced in part by fungal enzymes, can irritate the follicular epithelium and potentiate local immune reactions [4,6]. Although healthy individuals also harbor Malassezia, it is in acneic follicles—where poral blockage, excessive sebum, and immune activation converge—that the yeast may shift from harmless commensal to inflammatory contributor.

Microbial Players Beyond Malassezia

Despite the growing attention on fungal aspects of acne, bacterial diversity also remains a factor. Staphylococcus epidermidis frequently coexists with C. acnes in acne lesions, though its exact role (protective or pathogenic) remains debated. Corynebacterium species appear sporadically, and some studies identify Candida yeasts in a subset of acne-like lesions [9,10,13]. Moreover, advanced metagenomic approaches occasionally detect Demodex-associated bacteria and even viruses. Altogether, these findings suggest that acne’s microbial ecology is broader and more dynamic than once thought, challenging the traditional focus on a single bacterial species.

Mechanistic Insights: Fungal-Bacterial Interactions

Recent research points to complex metabolic interplay between C. acnes and Malassezia. Both produce lipases capable of releasing irritant fatty acids from sebum, possibly escalating comedogenesis [4,6,8,11]. Fungal cell wall structures can activate innate immune receptors (e.g., dectin-1), while C. acnes activates Toll-like receptor 2, each pathway potentially synergizing inflammatory cascades. Some investigators hypothesize that Malassezia may alter the local environment—by altering pH or lipid composition—in ways that either promote C. acnes proliferation or aggravate tissue damage. Untangling these cross-kingdom interactions is a key frontier in acne microbiome research.

Gaps in Current Research

While recent data strongly support a polymicrobial model, important questions remain. First, large-scale clinical trials that directly target Malassezia in acne are scarce. Anecdotal evidence and small case series suggest antifungals may benefit certain “fungal acne” presentations, but robust randomized studies are needed to confirm this for classic acne [6]. Second, absolute quantification of Malassezia cells within lesions—rather than just relative abundance—could clarify whether the yeast actively expands in acne or simply becomes more inflammatory. Third, the precise immune signatures associated with fungal-rich lesions remain underexplored. Investigations linking specific immune markers to Malassezia load could reveal if a subset of acne patients are particularly responsive to fungal dysbiosis. Finally, the role of environmental factors—sebaceous gland activity, humidity, and personal microbiome differences—must be examined longitudinally to distinguish predisposing microbial shifts from those occurring after lesion formation.

Conclusion

The emerging consensus from robust molecular and microbiome-based studies is that acne vulgaris is a dysbiotic condition involving a complex community of bacteria and fungi, with Malassezia species playing a more significant role than formerly appreciated [7,8]. Far from being a mere bystander, these yeasts coexist with Cutibacterium acnes in clogged follicles, collectively driving lipase-mediated irritation and inflammatory responses. Ongoing research will further elucidate how fungal and bacterial actors collaborate or compete within the sebaceous follicle. This broader, microbiome-centric paradigm holds promise for novel therapeutic strategies—potentially targeting multiple microbial pathways simultaneously.

Importantly, some have advocated for a microbiome-centric view of acne for years, including clinical and research groups such as Malezia, often encountering skepticism rooted in the traditional bacterial model. Now, with advanced sequencing data in hand, it is increasingly clear that successful acne management demands an integrative, ecological framework. Future approaches may combine antibacterials, antifungals, and probiotic or postbiotic interventions to restore microbial harmony in sebaceous follicles. These concepts challenge us to reassess how we diagnose and treat a condition that affects millions—and to recognize the complex microbial communities residing within every lesion.

References

  1. Song YC, Hahn HJ, Kim JY, Ko JH, Lee YW, Choe YB, Ahn KJ. Epidemiologic Study of Malassezia Yeasts in Acne Patients by Analysis of 26S rDNA PCR-RFLP. Ann Dermatol. 2011 Aug;23(3):321-8. doi: 10.5021/ad.2011.23.3.321. Epub 2011 Aug 6. PMID: 21909202; PMCID: PMC3162261.

  2. Numata S, Akamatsu H, Akaza N, Yagami A, Nakata S, Matsunaga K. Analysis of facial skin-resident microbiota in Japanese acne patients. Dermatology. 2014;228(1):86-92. doi: 10.1159/000356777. Epub 2013 Dec 20. PMID: 24356463. 

  3. Zhang XE, Zheng P, Ye SZ, Ma X, Liu E, Pang YB, He QY, Zhang YX, Li WQ, Zeng JH, Guo J. Microbiome: Role in Inflammatory Skin Diseases. J Inflamm Res. 2024 Feb 15;17:1057-1082. doi: 10.2147/JIR.S441100. PMID: 38375021; PMCID: PMC10876011.

  4. Akaza N, Akamatsu H, Numata S, Yamada S, Yagami A, Nakata S, Matsunaga K. Microorganisms inhabiting follicular contents of facial acne are not only Propionibacterium but also Malassezia spp. J Dermatol. 2016 Aug;43(8):906-11. doi: 10.1111/1346-8138.13245. Epub 2015 Dec 24. PMID: 26705192.

  5. Leeming JP, Holland KT, Cuncliffe WJ. The microbial colonization of inflamed acne vulgaris lesions. Br J Dermatol. 1988 Feb;118(2):203-8. doi: 10.1111/j.1365-2133.1988.tb01775.x. PMID: 2964856.

  6. Xu H, Li H. Acne, the Skin Microbiome, and Antibiotic Treatment. Am J Clin Dermatol. 2019 Jun;20(3):335-344. doi: 10.1007/s40257-018-00417-3. PMID: 30632097; PMCID: PMC6534434.

  7. Tsubuku H, Tsuboi R. Microbiota analysis of pustules in acne vulgaris patients: special focus on Malassezia species. J Tokyo Med Univ. 2020;78(1):48-54.
  8. Akaza N, Takasaki K, Nishiyama E, Usui A, Miura S, Yokoi A, Futamura K, Suzuki K, Yashiro Y, Yagami A. The Microbiome in Comedonal Contents of Inflammatory Acne Vulgaris is Composed of an Overgrowth of Cutibacterium Spp. and Other Cutaneous Microorganisms. Clin Cosmet Investig Dermatol. 2022 Sep 21;15:2003-2012. doi: 10.2147/CCID.S379609. PMID: 36172249; PMCID: PMC9510696.
  9. Omran AN, Mansori AG. Pathogenic Yeasts Recovered From Acne Vulgaris: Molecular Characterization and Antifungal Susceptibility Pattern. Indian J Dermatol. 2018 Sep-Oct;63(5):386-390. doi: 10.4103/ijd.IJD_351_17. PMID: 30210159; PMCID: PMC6124225.

  10. Guo Z, Yang Y, Wu Q, Liu M, Zhou L, Zhang L, Dong D. New insights into the characteristic skin microorganisms in different grades of acne and different acne sites. Front Microbiol. 2023 Apr 27;14:1167923. doi: 10.3389/fmicb.2023.1167923. PMID: 37180251; PMCID: PMC10172595.

  11. Zhang XE, Zheng P, Ye SZ, Ma X, Liu E, Pang YB, He QY, Zhang YX, Li WQ, Zeng JH, Guo J. Microbiome: Role in Inflammatory Skin Diseases. J Inflamm Res. 2024 Feb 15;17:1057-1082. doi: 10.2147/JIR.S441100. PMID: 38375021; PMCID: PMC10876011.
  12. Maître M, Gravier E, Simcic-Mori A, Géniès C, Mias C, Alvarez-Georges S, Noustens A, Bouyer K, Bessou-Touya S, Carballido F, Duplan H. Characterization of the forehead skin microbiome in the early phase of acne. J Eur Acad Dermatol Venereol. 2024 Aug;38 Suppl 7:3-11. doi: 10.1111/jdv.20203. PMID: 39051132.
  13. Naik B, Sasikumar J, B V, Das SP. Fungal coexistence in the skin mycobiome: a study involving Malassezia, Candida, and Rhodotorula. AMB Express. 2024 Feb 20;14(1):26. doi: 10.1186/s13568-024-01674-8. PMID: 38376644; PMCID: PMC10879058.


Back to Research